Ashina M. Migraine. N Engl J Med [Internet]. 2020 Nov 4 [cited 2021 Mar 10]; Available from: https://www.nejm.org/doi/pdf/10.1056/NEJMra1915327

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition. Cephalalgia Int J Headache. 2018;38:1–211. https://doi.org/10.1177/0333102417738202.

Rasmussen BK, Olesen J (1992) Migraine with aura and migraine without aura: an epidemiological study. Cephalalgia Int. J Headache 12(4):221–228 discussion 186

CAS  Google Scholar 

Russell MB, Rasmussen BK, Fenger K, Olesen J (1996) Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia Int J Headache 16(4):239–245

Article  CAS  Google Scholar 

Kececi H, Dener S (2002) Epidemiological and clinical characteristics of migraine in Sivas. Turkey Headache 42(4):275–280

Article  Google Scholar 

Baykan B, Ekizoglu E, Karli N, Kocasoy-Orhan E, Zarifoglu M, Saip S et al (2016) Characterization of Migraineurs having allodynia: results of a large population-based study. Clin J Pain 32(7):631–635

Article  Google Scholar 

Santoro G, Bernasconi F, Sessa F, Venco A (1990) Premonitory symptoms in migraine without aura: a clinical investigation. Funct Neurol 5(4):339–344

CAS  Google Scholar 

Karli N, Zarifoglu M, Calisir N, Akgoz S (2005) Comparison of pre-headache phases and trigger factors of migraine and episodic tension-type headache: do they share similar clinical pathophysiology? Cephalalgia Int J Headache 25(6):444–451

Article  CAS  Google Scholar 

Kelman L (2006) Migraine changes with age: IMPACT on migraine classification. Headache 46(7):1161–1171

Article  Google Scholar 

Quintela E, Castillo J, Muñoz P, Pascual J (2006) Premonitory and resolution symptoms in migraine: a prospective study in 100 unselected patients. Cephalalgia Int J Headache 26(9):1051–1060

Article  CAS  Google Scholar 

Schoonman GG, Evers DJ, Terwindt GM, van Dijk JG, Ferrari MD (2006) The prevalence of premonitory symptoms in migraine: a questionnaire study in 461 patients. Cephalalgia Int J Headache 26(10):1209–1213

Article  CAS  Google Scholar 

Schulte LH, Jürgens TP, May A (2015) Photo-, osmo- and phonophobia in the premonitory phase of migraine: mistaking symptoms for triggers? J Headache Pain 15(16):14

Article  Google Scholar 

Laurell K, Artto V, Bendtsen L, Hagen K, Häggström J, Linde M et al (2016) Premonitory symptoms in migraine: a cross-sectional study in 2714 persons. Cephalalgia Int J Headache 36(10):951–959

Article  Google Scholar 

Viana M, Sances G, Ghiotto N, Guaschino E, Allena M, Nappi G et al (2016) Variability of the characteristics of a migraine attack within patients. Cephalalgia Int J Headache 36(9):825–830

Article  CAS  Google Scholar 

Güven B, Güven H, Çomoğlu SS (2018) Migraine and yawning. Headache 58(2):210–216

Article  Google Scholar 

Schwedt TJ, Peplinski J, Garcia-Filion P, Berisha V (2019) Altered speech with migraine attacks: a prospective, longitudinal study of episodic migraine without aura. Cephalalgia Int J Headache 39(6):722–731

Article  Google Scholar 

Gago-Veiga AB, Pagán J, Henares K, Heredia P, González-García N, De Orbe MI et al (2018) To what extent are patients with migraine able to predict attacks? J Pain Res 11:2083–2094

Article  Google Scholar 

Wang X, Yin Z, Lian Y, Xu Y, Li Y, Liu J et al (2021) Premonitory symptoms in migraine from China: a multi-clinic study of 4821 patients. Cephalalgia Int J Headache 41(9):991–1003

Article  CAS  Google Scholar 

Eigenbrodt AK, Christensen RH, Ashina H, Iljazi A, Christensen CE, Steiner TJ, Lipton RB, Ashina M. Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency. J Headache Pain. 2022;23(1):140.

Martinelli D, Pocora MM, De Icco R, Putortì A, Tassorelli C (2022) Triggers of migraine: where do we stand? Curr Opin Neurol 35(3):360–366

Article  CAS  Google Scholar 

Dodick DW (2018) A phase-by-phase review of Migraine pathophysiology. Headache 58(Suppl 1):4–16

Article  Google Scholar 

Goadsby PJ, Holland PR, Martins-Oliveira M, Hoffmann J, Schankin C, Akerman S (2017) Pathophysiology of Migraine: a disorder of sensory processing. Physiol Rev 97(2):553–622

Article  Google Scholar 

Pavlovic JM, Buse DC, Sollars CM, Haut S, Lipton RB (2014) Trigger factors and premonitory features of migraine attacks: summary of studies. Headache 54(10):1670–1679

Article  Google Scholar 

Lipton RB, Pavlovic JM, Haut SR, Grosberg BM, Buse DC (2014) Methodological issues in studying trigger factors and premonitory features of migraine. Headache 54(10):1661–1669

Article  Google Scholar 

Schulte LH, Peng KP (2019) Current understanding of premonitory networks in migraine: a window to attack generation. Cephalalgia 39(13):1720–1727

Article  Google Scholar 

Karsan N, Goadsby PJ (2018) Biological insights from the premonitory symptoms of migraine. Nat Rev Neurol 14(12):699–710

Article  Google Scholar 

Headache classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia Int J Headache. 1988; 8(Suppl 7):1–96.

Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd. Cephalalgia Int J Headache. 2004;24 Suppl 1:9–160.

Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia Int J Headache 2013;33(9):629–808

Holland P, Goadsby PJ (2007) The hypothalamic orexinergic system: pain and primary headaches. Headache 47(6):951–962

Article  Google Scholar 

Martins-Oliveira M, Tavares I, Goadsby PJ (2021) Was it something I ate? Understanding the bidirectional interaction of migraine and appetite neural circuits. Brain Res 1(1770):147629

Article  Google Scholar 

Bartsch T, Levy MJ, Knight YE, Goadsby PJ (2004) Differential modulation of nociceptive dural input to [hypocretin] orexin a and B receptor activation in the posterior hypothalamic area. Pain 109(3):367–378

Article  CAS  Google Scholar 

Holland PR, Akerman S, Goadsby PJ (2006) Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci 24(10):2825–2833

Article  CAS  Google Scholar 

Holland PR, Akerman S, Goadsby PJ (2005) Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther 315(3):1380–1385

Article  CAS  Google Scholar 

Hoffmann J, Supronsinchai W, Akerman S, Andreou AP, Winrow CJ, Renger J et al (2015) Evidence for orexinergic mechanisms in migraine. Neurobiol Dis 74:137–143

Article  CAS  Google Scholar 

Jansen I, Uddman R, Ekman R, Olesen J, Ottosson A, Edvinsson L (1992) Distribution and effects of neuropeptide Y, vasoactive intestinal peptide, substance P, and calcitonin gene-related peptide in human middle meningeal arteries: comparison with cerebral and temporal arteries. Peptides 13(3):527–536

Article  CAS  Google Scholar 

Yu XJ, Moskowitz MA (1996) Neuropeptide Y Y2 receptor-mediated attenuation of neurogenic plasma extravasation acting through pertussis toxin-sensitive mechanisms. Br J Pharmacol 119(2):229–232

Article  CAS  Google Scholar 

Oliveira MM, Akerman S, Tavares I, Goadsby PJ (2016) Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: implications for migraine. Pain 157(8):1666–1673

Article  CAS  Google Scholar 

Charbit AR, Akerman S, Holland PR, Goadsby PJ (2009) Neurons of the dopaminergic/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the Trigeminocervical complex: an electrophysiological and Immunohistochemical study. J Neurosci 29(40):12532–12541

Article  CAS  Google Scholar 

Charbit AR, Akerman S, Goadsby PJ (2009) Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex. J Pharmacol Exp Ther 331(2):752–763

Article  CAS  Google Scholar 

Bergerot A, Storer RJ, Goadsby PJ (2007) Dopamine inhibits trigeminovascular transmission in the rat. Ann Neurol 61(3):251–262

Article  CAS  Google Scholar 

Abdallah K, Monconduit L, Artola A, Luccarini P, Dallel R (2015) GABAAergic inhibition or dopamine denervation of the A11 hypothalamic nucleus induces trigeminal analgesia. Pain 156(4):644–655

Article  CAS  Google Scholar 

Chabi A, Zhang Y, Jackson S, Cady R, Lines C, Herring WJ et al (2015) Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis. Cephalalgia Int J Headache 35(5):379–388

Article  Google Scholar 

Tajti J, Szok D, Majláth Z, Tuka B, Csáti A, Vécsei L (2015) Migraine and neuropeptides. Neuropeptides 52:19–30

Article  CAS  Google Scholar 

Jansen I, Uddman R, Hocherman M, Ekman R, Jensen K, Olesen J et al (1986) Localization and effects of neuropeptide Y, vasoactive intestinal polypeptide, substance P, and calcitonin gene-related peptide in human temporal arteries. Ann Neurol 20(4):496–501

Article  CAS  Google Scholar 

Tajti J, Uddman R, Möller S, Sundler F, Edvinsson L (1999) Messenger molecules and receptor mRNA in the human trigeminal ganglion. J Auton Nerv Syst 76(2–3):176–183

Article  CAS  Google Scholar 

Charbit AR, Akerman S, Goadsby PJ (2010) Dopamine: what’s new in migraine? Curr Opin Neurol 23(3):275–281

Article  CAS  Google Scholar 

Silberstein SD, Young WB, Mendizabal JE, Rothrock JF, Alam AS (2003) Acute migraine treatment with droperidol: a randomized, double-blind, placebo-controlled trial. Neurology 60(2):315–321

Article  CAS  Google Scholar 

Colman I, Brown MD, Innes GD, Grafstein E, Roberts TE, Rowe BH (2004 18;bmj;bmj.38281.595718.7Cv1) Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials. BMJ 329(7479):1369

Article  CAS  Google Scholar 

Eken C (2015) Critical reappraisal of intrave